Publication | Closed Access

Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome

Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematologyPharmacologySodium PhenylbutyrateMyeloid NeoplasiaPharmacotherapyOncologyPilot Study